,address1,address2,city,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Dr. Miroslav  Reljanovic', 'age': 63, 'title': 'Founder & Exec. Chairman', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 964296, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
1,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Mr. Michael William Spiteri', 'age': 61, 'title': 'Chief Transformation & Technology Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 52769, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
2,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Jonathan Andrew Curtain', 'age': 46, 'title': 'CFO & Exec. Director', 'yearBorn': 1976, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
3,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Dr. Michael  Forstner', 'title': 'Head of Risk Management & Pharmacoepidemiology', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
4,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Ms. Sally  Amanuel', 'title': 'Pres of PrimeVigilance', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
5,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Dr. Gordana  Tonkovic', 'title': 'Pres of Clinical Research', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
6,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Ms. Ronel  Steyn', 'title': 'Sr. VP of Global Devel.', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
7,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Keith  Byrne', 'title': 'Sr. Vice-Pres of Capital Markets & Strategy', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
8,Surrey Research Park,1 Occam Court,Guildford,GU2 7HJ,United Kingdom,44 1483 503 205,https://www.ergomedplc.com,Biotechnology,Healthcare,"Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, and internationally. The company operates through two segments, Clinical Research Services and Pharmacovigilance. It provides and manages clinical development, trial management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. The company focuses on various therapeutic areas, including oncology, hematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. It also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.",1400,"{'maxAge': 1, 'name': 'Joanne  Bletcher', 'title': 'Company Sec.', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,1350.0,1358.0,0.0,0.837087,4655.1724,26.132404,278010,278010,276862,1436654,1436654,1350.0,1352.0,0,0,686456064,895.0,1380.0,4.725641,1111.44,1116.11,0.0,0.0,GBp,664222848,0.103140004,35120793,50848600,0.18167,0.71116996,1.685,801.18695,1672444800,1703980800,1672444800,0.269,14982000,0.29,51.66,4.573,27.559,LSE,EQUITY,ERGO.L,ERGO.L,ERGOMED PLC ORD 1P,Ergomed plc,1405407600,Europe/London,BST,3600000,1350.0,1600.0,1325.0,1420.63,1400.0,2.0,buy,8,19096000,0.379,24102000,2908000,1.419,1.497,145262000,3.431,2.918,0.109110005,0.19715,80550000,10861625,14849000,0.241,0.205,0.55452,0.16591999,0.14141,GBP,
